Premium
Strategies for immunoisolation in islet transplantation: challenges for the twenty‐first century
Author(s) -
Ohgawara Hisako
Publication year - 2000
Publication title -
journal of hepato‐biliary‐pancreatic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.63
H-Index - 60
eISSN - 1868-6982
pISSN - 0944-1166
DOI - 10.1007/s005340070032
Subject(s) - transplantation , membrane , semipermeable membrane , islet , enteroendocrine cell , agarose , chemistry , immunosuppression , secretion , biomedical engineering , medicine , microbiology and biotechnology , endocrine system , biophysics , insulin , endocrinology , biology , chromatography , biochemistry , hormone
A number of investigations have pursued the feasibility of a bioartificial endocrine pancreas (Bio‐AEP) in which pancreatic endocrine cells (PE‐cells) are encapsulated within a semipermeable membrane to protect them from immunological rejection. The goal of PE‐cell transplantation in human diabetes is to maintain the PE‐cell graft in the recipient without the use of immunosuppression. One approach is to encapsulate the donor PE‐cells in a semipermeable membrane. A type of diffusion chamber for a Bio‐AEP is described. The system is based on a chamber designed to improve the diffusion of insulin secretion in response to glucose transfer across a membrane. An implantable diffusion chamber for the Bio‐AEP was constructed by placing PE‐cells in agarose, containing nicotinamide and a sugar‐chain coated polymer, in a ring holder which was sandwiched between two nucleopore membranes (pore size 0.1 μm), for transplantation into diabetic animals. This compatible diffusion chamber prevented rejection, and maintained normoglycemia in diabetic rats when implanted intraperitoneally.